Order Online! Now! Get your $50 coupon for online order.
Get 50% off discount for CGT related product lines!
Our limited edition HOLIDAYS LLAMA is here! Place any order now to recieve one!
Earn Loyalty Rewards! Up to $155 Amazon Gift Card
Time Limited Offer: Welcome Gift for New Customers !
Time Limited Offer: Welcome Gift for New Customers !
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CRS-A025 | Human | resDetect™ Human Interleukin-7 (IL-7) ELISA Kit (Residue Testing) | |||
IL7-Y84 | Mouse | Mouse IL-7 Antibody, Mouse IgG1 (4C9F12) |
![]() ![]() |
![]() ![]() |
|
IL7-M52H3 | Mouse | Mouse IL-7 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GMP-L07H24 | Human | GMP Human IL-7 Protein | ![]() |
![]() ![]() |
|
IL7-H5253 | Human | Human IL-7 Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
IL7-H4219 | Human | Human IL-7 Protein, premium grade | ![]() |
![]() ![]() |
GMP Human IL-7 Protein (Cat. No. GMP-L07H24) stimulates proliferation of PHA-P-activated human peripheral blood mononuclear cell (PBMC). The specific activity of GMP Human IL-7 is > 1.0ⅹ10^8 IU/mg, which is calibrated against human IL-7 WHO International Standard (NIBSC code: 90/530) (QC tested).
Mouse IL-7 Antibody, Mouse IgG1 (4C9F12) (Cat. No. IL7-Y84) immobilized on CM5 Chip can bind Human IL-7, premium grade (Cat. No. IL7-H4219) with an affinity constant of 2.83 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine) | Phase 1 Clinical | Hunan Zhaotai Yongren Biotech Co Ltd, Guangdong Zhaotai Invivo Biomedicine Co Ltd | Carcinoma, Squamous Cell; Carcinoma, Hepatocellular | Details | |
CT0181 | CT-0181 | Phase 1 Clinical | CARsgen Therapeutics Holdings Ltd | Carcinoma, Hepatocellular | Details |
This web search service is supported by Google Inc.